Correlation Between Seres Therapeutics and Scpharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Scpharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Scpharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Scpharmaceuticals, you can compare the effects of market volatilities on Seres Therapeutics and Scpharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Scpharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Scpharmaceuticals.
Diversification Opportunities for Seres Therapeutics and Scpharmaceuticals
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Seres and Scpharmaceuticals is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Scpharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scpharmaceuticals and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Scpharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scpharmaceuticals has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Scpharmaceuticals go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Scpharmaceuticals
Given the investment horizon of 90 days Seres Therapeutics is expected to under-perform the Scpharmaceuticals. In addition to that, Seres Therapeutics is 1.7 times more volatile than Scpharmaceuticals. It trades about -0.21 of its total potential returns per unit of risk. Scpharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 331.00 in Scpharmaceuticals on October 20, 2024 and sell it today you would lose (3.00) from holding Scpharmaceuticals or give up 0.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Scpharmaceuticals
Performance |
| Timeline |
| Seres Therapeutics |
| Scpharmaceuticals |
Seres Therapeutics and Scpharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Scpharmaceuticals
The main advantage of trading using opposite Seres Therapeutics and Scpharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Scpharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will offset losses from the drop in Scpharmaceuticals' long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |